Our vision is to improve the treatment of severe diseases. Working with the medicines of the future we focus on oncology.

Human Health

Human HealthOur main goal is to develop new pharmaceuticals with high versatility were there are wide-spread medical needs.

Further reading »


Animal Health

Animal HealthAnimal Health develops and improves existing medical treatments focusing on oncology.

Further reading »


The Share

Latest News

Prospectus, including new financial information, regarding Oasmia Pharmaceutical's rights issue is now available

November 17 2014
Further reading »

Oasmia Pharmaceutical AB announces a fully committed and underwritten rights issue of approximately SEK 176 million.

November 11 2014
Further reading »

Oasmia’s lead human oncology product Paclical shows a positive risk/benefit profile versus standard treatment in pivotal phase III clinical study

October 21 2014
Submission for European marketing approval of Paclical in 2015
Further reading »

bottom